Filing Flows › Usana Health Sciences (USNA) › Capital expenditures
Usana Health Sciences (USNA) capital expenditures by quarter
Usana Health Sciences' capital expenditures were $3.2M in Q2 2026 (second quarter 2026), +19% from Q1 2026. Over the last 5 quarters it ranged from $1.8M (Q4 2024) to $5.0M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.2M | +19% | -37% |
| Q1 2026 | $2.6M | -47% | -6% |
| Q2 2025 | $5.0M | +79% | — |
| Q1 2025 | $2.8M | +56% | — |
| Q4 2024 | $1.8M | — | — |
Q2 2026 at a glance
Usana Health Sciences, Q2 2026: revenue $223M (-5% year over year), operating margin -9.0%, net loss $28.0M, operating cash flow $23.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Usana Health Sciences' capital expenditures?
Usana Health Sciences' capital expenditures were $3.2M in Q2 2026 (second quarter 2026), +19% from Q1 2026.
How has Usana Health Sciences' capital expenditures changed?
Over the last 5 quarters it ranged from $1.8M (Q4 2024) to $5.0M (Q2 2025).